scibac

About:

SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.

Twitter/X: SciBacInc

Top Investors: National Institutes of Health, CARB-X, Breakout Labs

Description:

SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.The company's technology improves beneficial microorganisms using a patented MERGE platform that uses a type of directed evolution to increase therapeutic efficacy. Its first two therapeutics treat chronic infections in cystic fibrosis for Pseudomonas, Staph, Burkholderia, and NTM.

Total Funding Amount:

$4.05M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Burlingame, California, United States

Founded Date:

2015-01-01

Contact Email:

INFO(AT)SCIBAC.COM

Founders:

Anthony Cann, Derik Twomey, Jeanette Mucha

Number of Employees:

1-10

Last Funding Date:

2019-07-09

IPO Status:

Private

Industries: